We are live on ! Find out more
JAZZ icon

Jazz Pharmaceuticals
JAZZ

406 hedge funds and large institutions have $6.55B invested in Jazz Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 162 increasing their positions, 137 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more repeat investments, than reductions

Existing positions increased: 162 | Existing positions reduced: 137

18% more call options, than puts

Call options by funds: $35.5M | Put options by funds: $30.1M

1.42% more ownership

Funds ownership: 88.93% → 90.35% (+1.4%)

2% less funds holding

Funds holding: 416 → 406 (-10)

9% less capital invested

Capital invested by funds: $7.16B → $6.55B (-$612M)

19% less first-time investments, than exits

New positions opened: 44 | Existing positions closed: 54

57% less funds holding in top 10

Funds holding in top 10: 7 → 3 (-4)

Holders
406
Holders Change
-10
Holders Change %
-2.4%
% of All Funds
8.9%
Holding in Top 10
3
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-57.14%
% of All Funds
0.07%
New
44
Increased
162
Reduced
137
Closed
54
Calls
$35.5M
Puts
$30.1M
Net Calls
+$5.43M
Net Calls Change
-$2.86M

Top Buyers

1
LSV Asset Management
LSV Asset Management
Illinois
+$79.6M
2
Renaissance Technologies
Renaissance Technologies
New York
+$75.3M
3
AQR Capital Management
AQR Capital Management
Connecticut
+$37M
4
Goldman Sachs
Goldman Sachs
New York
+$36.6M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$29.1M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$139M
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$48.4M
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$25.3M
4
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
-$23.7M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$20.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIC
401
Ameritas Investment Company
Nebraska
$1K +$1.21K +9 New
IA
402
IFP Advisors
Florida
$1K +$1.21K +9 New
RCAG
403
Rehmann Capital Advisory Group
Michigan
$896 – – –
SI
404
Scout Investments
Missouri
– -$13M -91,123 Closed
Two Sigma Investments
405
Two Sigma Investments
New York
– -$10.5M -78,677 Closed
ACM
406
Asymmetry Capital Management
California
– -$9.12M -63,940 Closed
CTA
407
Carillon Tower Advisers
Florida
– -$8.83M -61,925 Closed
EAM
408
EULAV Asset Management
Florida
– -$6.42M -45,000 Closed
SEC
409
Seven Eight Capital
New York
– -$3.5M -24,517 Closed
Bank of Nova Scotia
410
Bank of Nova Scotia
Ontario, Canada
– -$3.29M -23,064 Closed
Tudor Investment Corp
411
Tudor Investment Corp
Connecticut
– -$2.76M -19,380 Closed
BCM
412
Bayesian Capital Management
New York
– -$2.28M -16,007 Closed
Verition Fund Management
413
Verition Fund Management
Connecticut
– -$1.81M -12,690 Closed
DCM
414
Dupont Capital Management
Delaware
– -$1.37M -9,613 Closed
PL
415
Polianta Ltd
Jersey
– -$1.19M -8,350 Closed
CIA
416
Capital Impact Advisors
Massachusetts
– -$1.06M -7,699 Closed
SL
417
Signition LP
New York
– -$1.1M -7,698 Closed
SOADOR
418
State of Alaska Department of Revenue
Alaska
– -$973K -6,835 Closed
QIM
419
Quantitative Investment Management
Virginia
– -$619K -4,348 Closed
Connor, Clark & Lunn Investment Management (CC&L)
420
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$503K -3,525 Closed
QCM
421
Quantinno Capital Management
New York
– -$464K -3,258 Closed
BOE
422
Bank of Edwardsville
Illinois
– -$454K -3,182 Closed
Cambridge Investment Research Advisors
423
Cambridge Investment Research Advisors
Iowa
– -$425K -2,979 Closed
OI
424
Oakbrook Investments
Illinois
– -$413K -2,900 Closed
Nomura Holdings
425
Nomura Holdings
Japan
– -$406K -2,852 Closed
15 16
17
18 19

JAZZ Hedge Fund Activity: Q3 2019 in Review

406 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Jazz Pharmaceuticals (JAZZ) for Q3 2019, worth a combined $6.55B — down 8.5% from $7.16B a quarter earlier.

Sellers outnumbered buyers: 54 funds closed out of JAZZ and 44 opened new positions — a net loss of 10 holders — while 137 trimmed existing stakes and 162 added.

The largest buyer was LSV Asset Management, adding an estimated $79.6M. The largest seller was Fidelity Investments, cutting an estimated $139M.

  • 406 institutional investors held Jazz Pharmaceuticals (JAZZ) as of Q3 2019, down from 416 in Q2 2019.
  • Funds reported $6.55B of Jazz Pharmaceuticals stock for Q3 2019, down 8.5% quarter-over-quarter.
  • 44 funds opened new Jazz Pharmaceuticals positions in Q3 2019 and 54 closed out, a net change of -10 holders.
  • The largest Jazz Pharmaceuticals buyer in Q3 2019 was LSV Asset Management, an estimated $79.6M added.
  • The largest Jazz Pharmaceuticals seller in Q3 2019 was Fidelity Investments, an estimated $139M sold.

Based on aggregated 13F filings for Q3 2019.